CD44 and head and neck squamous cell carcinoma: In our previous study, we suggested that both CD44+ and CD271+ were suitable markers to isolate CSCs from HNSCC.16 In the current study, we used these FACS-sorted CD44+/CD271+ CSCs to examine the effect of SF/chemotherapy-combination treatments.